Digital Therapeutic for Parkinson's Disease
Holistic support for the evolving challenges of Parkinson's disease
Our digital therapeutic (DTx) is designed to provide holistic support for patients living with the evolving challenges of Parkinson’s disease. It is adaptable to different therapies and stages of disease progression and is ready to be customized to the individual requirements of a pharma company.
Through guidance, exercises, reminders, and education our DTx contributes to therapy adherence and persistence as well as helping patients maintain quality of life. It also delivers invaluable real-world insights to pharma companies and health care professionals (HCPs).
Support to improve adherence and persistence
Our DTx for Parkinson’s disease provides guidance on therapy administration and integrates reminders and symptom tracking into daily routines. This addresses challenges of long-term pharmacological therapy persistence and adherence which can drop significantly as regimens become more complex*.
Patients are supported with:
Drug administration guidance and timely reminders
Tracking of administration
Daily symptom monitoring and education
*Source: Michela Tinelli et al. (2016), Parkinson.org, Kulkarni AS et al. (2008), Congress of the European Academy of Neurology (2022)
Benefits
Patient adherence support
Supports therapy adherence and persistence with patient guidance, reminders, symptom tracking, and education.
Assistance to maintain QoL
Exercises for motor and non-motor symptom management help support patients’ emotional wellbeing, mobility, and confidence in daily life.
Insights from RWE
Provides clinically meaningful data on treatment journey and experience to pharma and HCPs for evaluation and evidence to regulators and payors.
Holistic help to maintain quality of life
Research shows that many patients have limited access to the multidisciplinary care that could help manage disease symptoms. Our DTx supports patients in early to mid stages of disease progression by supplementing physiotherapy, speech therapy, and cognitive behavioral therapy (CBT). This can support emotional wellbeing, mobility, and confidence in daily life. The app provides:
Personalized daily routines and behavioral support
Evidence-based exercises to address:
Motor symptoms such as tremors, bradykinesia, dyskinesia
Psychological, cognitive and other non-motor symptoms
Education and information to help patients better understand their disease and make informed decision
RWE of a patient’s therapy journey
Our DTx continuously captures and transmits structured, clinically meaningful data on patient treatment journeys and experience. Potential aggregated insights can show adherence vs. symptom correlation across user cohorts and QoL. This can support pharma publications, HEOR dossiers and demonstrate long-term outcomes to regulators and payers. Data could include:
Engagement metrics – demonstrates behavioral activation and patient motivation
Retention and program completion – indicates real-world feasibility
Quality of life (QoL) indicators – patient-reported outcomes
Experience and understanding of Parkinson’s disease
Our expert team has conducted in-depth research and engaged with patients and healthcare professionals to better understand the real-world challenges faced by patients with this degenerative disease.
A combination product based on our Gx InPuls™ Flex belt-worn infusor is already on the market for administration of apomorphine. Through this development project our multidisciplinary team gained extensive experience in developing solutions to meet the needs of patients with Parkinson’s disease.
Global multidisciplinary pharma expertise
We develop smart, connected solutions that seamlessly integrate with your drug delivery systems – enhancing patient engagement, monitoring adherence, and generating real-world insights.
Our multidisciplinary team spans experts in pharma, human-centered design, software development, and medical sciences. They collaborate closely with our partners to co-create digital health solutions that truly respond to identified needs and challenges.
By combining Gerresheimer’s proven drug delivery expertise with digital innovation, we help you to deliver more than medication: we enable a connected care experience that brings value to you, your patients, and healthcare providers.
Contact the expert
Nico Grygas
Digital Solution Lead, Digital Health Solutions
